The Department of Surgery at the Washington University School of Medicine in St. Louis (WUSM) requests continued funding to support a training grant in surgical oncology for surgical residents who are planning careers devoted to oncology in the specialties of general, pediatric, and thoracic surgery. Additionally, we are specifically asking for two additional dedicated positions to support trainees in gynecologic oncology. This grant will support a comprehensive educational program in laboratory research in cell and developmental biology, immunobiology, molecular biology and molecular genetics/genomics. Three to five surgical residents and two gynecologic fellows will be selected annually for this research training program through a rigorous and highly competitive process. The selection committee is composed of the program director of the training grant as well as an advisory committee. The majority of the surgical oncology trainees will be from the WUSM surgical residency. Two slots per year will be for Gynecology fellows. The long-term objective of this program is to prepare surgical/gynecology trainees, through intensive educational programs and monitored experiences in investigative research to become independent scientific investigators and to acquire faculty positions in academic departments as well as to become leading physician scientists. The success of this program is attested to by the fact that of 16 residents who have completed the program over the past 10 years, ten (62.5 percent) now hold full-time faculty positions, several with peer-reviewed funding. The Department of Surgery at WUSM has approximately 45,000 nsf of laboratory research space and over $22 million of peer-reviewed annual research support plus $2.5 million of annual clinical research support. The participating faculty have grant support in excess of $45 million. Adding to this superb environment is the Siteman Cancer Center (SCC) which is an NCI designated comprehensive cancer center. The Center treats 7,000 cancer cases annually and receives approximately $130 million of annual grant support.

Public Health Relevance

This grant provides surgical/gynecologic trainees with all of the training to become independent scientific investigators and to obtain faculty positions in academic departments. With this training, they are poised to become the future leading physician scientists in this field.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Grieselhuber, Nicole R; Kodner, Ira J; Brown, Douglas et al. (2017) Confronting the therapeutic misconception. Surgery 162:183-187
Zhu, Yu; Herndon, John M; Sojka, Dorothy K et al. (2017) Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. Immunity 47:323-338.e6
Ethun, Cecilia G; Postlewait, Lauren M; McInnis, Mia R et al. (2017) The diagnosis of pancreatic mucinous cystic neoplasm and associated adenocarcinoma in males: An eight-institution study of 349 patients over 15 years. J Surg Oncol 115:784-787
BriseƱo, Carlos G; Gargaro, Marco; Durai, Vivek et al. (2017) Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A 114:3957-3962
Postlewait, Lauren M; Ethun, Cecilia G; McInnis, Mia R et al. (2017) Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study. JAMA Surg 152:19-25
Ohman, Kerri A; Liu, Jingxia; Linehan, David C et al. (2017) Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. HPB (Oxford) 19:449-457
Zhang, Xiuli; Kim, Samuel; Hundal, Jasreet et al. (2017) Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity. Cancer Immunol Res 5:516-523
Hashim, Yassar M; Vangveravong, Suwanna; Sankpal, Narendra V et al. (2017) The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. J Exp Clin Cancer Res 36:14
Yu, Jennifer; Elmore, Leisha C; Cyr, Amy E et al. (2017) Cost Analysis of a Surgical Consensus Guideline in Breast-Conserving Surgery. J Am Coll Surg 225:294-301
Elmore, Leisha C; Jeffe, Donna B; Jin, Linda et al. (2017) Defining and Mitigating Burnout: In Reply to Brisson and Bianchi. J Am Coll Surg 224:88-89

Showing the most recent 10 out of 151 publications